| Sources | Surface marker | Differentiation potential | Reference |
| BM-MSCs | CD271(+), CD59(+), CD81(+), CD47(+), CD151(+), CD147(+), CD98(+), CD143(-), Lin (-) CD45(-), CD140a (PDGFRα) (low/-) | Strong adipogenic and osteogenic potential, poor chondrogenic potential, strong differentiation potential of corneal epithelial cells, and cardiac progenitors | [14–18] | UC-MSCs | CD73(+), CD90(+), CD105(+), CD44(+), CDH-1(+), CD29(+), CD34(-), CD45(-) | Muscle, neurogenic cells, hepatocyte-like cells, endothelial lineage | [19–23] | AD-MSCs | CD45(-), HLA-DR(-), CD44(+), CD106(+), CD34(+), CD90(+), CD105(+) | Strong adipogenic and osteogenic potential, poor chondrogenic potential, poor differentiation potential of corneal and muscle | [14, 16, 17, 24–26] | DP-MSCs | TRO-1(+), CD146(+), CD29(+), CD90(+), CD105(+), CD44(+), CD59(+), CD73(+), CD146(-), CD34(-), CD45(-), CD11b(-), CD45(-) | Osteogenic, adipogenic, chondrogenic, fibroblast lineage, neural stem cells | [27, 28] | SD-MSCs | CD9(+), CD10(+), CD13(+), CD44(+), CD54(+), CD55(+), CD90(+), CD105(+), CD166(+), D7-FIB(+), CD14(-), CD20(-), CD45(-), CD133(-) | Strong chondrocyte, osteocyte, and adipocyte differentiation ability, as well as muscle differentiation | [16, 29] |
|
|